MedTrace Logo

PET-imaging of Unruptured Intracranial Aneurysm Inflammation

NCT04715503 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2021-01-20

No results posted yet for this study

Summary

The main purpose of this study is to determine if PET-imaging can be used to evaluate inflammation level of intracranial aneurysms, thus helping to evaluate the rupture risk of intracranial aneurysm.

Conditions

Interventions

RADIATION

PET imaging, 18F-FDG

PET-MRI with 18F-FDG

RADIATION

PET imaging, 68Ga-DOTANOC

PET-CT with 68Ga-DOTANOC

Sponsors & Collaborators

  • University of Turku

    collaborator OTHER

  • Turku University Hospital

    lead OTHER_GOV

Principal Investigators

  • Jaakko Rinne, MD, Prof. · Turku University Hospital, Neurocenter, Department of Neurosurgery, Division of Clinical Neurosciences, University Of Turku

  • Antti Saraste, MD, Prof. · Turku University Hospital, Heart Centre, University of Turku

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-01-14
Primary Completion
2022-01-31
Completion
2022-10-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04715503 on ClinicalTrials.gov